Drug Administration Schedule
"Drug Administration Schedule" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience.
| Descriptor ID |
D004334
|
| MeSH Number(s) |
E02.319.283
|
| Concept/Terms |
Drug Administration Schedule- Drug Administration Schedule
- Administration Schedule, Drug
- Administration Schedules, Drug
- Drug Administration Schedules
- Schedule, Drug Administration
- Schedules, Drug Administration
|
Below are MeSH descriptors whose meaning is more general than "Drug Administration Schedule".
Below are MeSH descriptors whose meaning is more specific than "Drug Administration Schedule".
This graph shows the total number of publications written about "Drug Administration Schedule" by people in this website by year, and whether "Drug Administration Schedule" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 38 | 38 |
| 1996 | 0 | 25 | 25 |
| 1997 | 0 | 47 | 47 |
| 1998 | 0 | 53 | 53 |
| 1999 | 0 | 51 | 51 |
| 2000 | 0 | 61 | 61 |
| 2001 | 1 | 61 | 62 |
| 2002 | 0 | 109 | 109 |
| 2003 | 0 | 106 | 106 |
| 2004 | 2 | 108 | 110 |
| 2005 | 2 | 120 | 122 |
| 2006 | 0 | 139 | 139 |
| 2007 | 1 | 131 | 132 |
| 2008 | 0 | 136 | 136 |
| 2009 | 0 | 126 | 126 |
| 2010 | 0 | 126 | 126 |
| 2011 | 3 | 127 | 130 |
| 2012 | 0 | 122 | 122 |
| 2013 | 0 | 144 | 144 |
| 2014 | 0 | 123 | 123 |
| 2015 | 0 | 132 | 132 |
| 2016 | 1 | 133 | 134 |
| 2017 | 0 | 110 | 110 |
| 2018 | 0 | 131 | 131 |
| 2019 | 2 | 125 | 127 |
| 2020 | 1 | 73 | 74 |
| 2021 | 2 | 43 | 45 |
| 2022 | 0 | 3 | 3 |
| 2023 | 0 | 2 | 2 |
| 2024 | 0 | 16 | 16 |
| 2025 | 0 | 1 | 1 |
Below are the most recent publications written about "Drug Administration Schedule" by people in Profiles.
-
Comparing the efficacy of different proton pump inhibitor dosing regimens for the treatment of gastroesophageal reflux disease: a systematic review and meta-analysis. Dis Esophagus. 2025 Jan 07; 38(1).
-
A weekly low-dose regimen of decitabine and venetoclax is efficacious and less myelotoxic in a racially diverse cohort. Blood. 2024 Nov 28; 144(22):2360-2363.
-
Association of Delayed Denosumab Dosing with Increased Risk of Fractures: A Population-Based Retrospective Study. Endocrinol Metab (Seoul). 2024 Dec; 39(6):946-955.
-
The limitation of lipidation: Conversion of semaglutide from once-weekly to once-monthly dosing. Proc Natl Acad Sci U S A. 2024 Nov 19; 121(47):e2415815121.
-
Secukinumab in adult patients with lichen planus: efficacy and safety results from the randomized placebo-controlled proof-of-concept PRELUDE study. Br J Dermatol. 2024 Oct 17; 191(5):680-690.
-
Sustained hair regrowth with continued ritlecitinib treatment through week 48 in patients with alopecia areata with or without early target responses: Post hoc analysis of the ALLEGRO phase 2b/3 trial. J Am Acad Dermatol. 2025 Feb; 92(2):276-284.
-
A phase III, open-label clinical trial evaluating pegunigalsidase alfa administered every 4 weeks in adults with Fabry disease previously treated with other enzyme replacement therapies. J Inherit Metab Dis. 2025 01; 48(1):e12795.
-
Heterogeneity in disease activity, frequency of treatments, and visual outcomes among patients with retinal vein occlusion: relationship between injection need and vision with as-needed ranibizumab. Br J Ophthalmol. 2024 Aug 22; 108(9):1216-1225.
-
Early Opioid Use and Postoperative Delirium Following Open Abdominal Aortic Aneurysm Repair. Ann Vasc Surg. 2024 Dec; 109:338-349.
-
Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women. N Engl J Med. 2024 Oct 03; 391(13):1179-1192.